COAGULATION factor V is a critical cofactor for the activation of prot
hrombin to thrombin, the penultimate step in the generation of a fibri
n blood clot(1,2). Genetic deficiency of factor V results in a congeni
tal bleeding disorder (parahaemophilia)(3), whereas inheritance of a m
utation rendering factor V resistant to inactivation is an important r
isk factor for thrombosis(4,5). We report here that approximately half
of homozygous embryos deficient in factor V (F upsilon(-/-)), which h
ave been generated by gene targeting, die at embryonic day (E) 9-10, p
ossibly as a result of an abnormality in the yolk-sac vasculature. The
remaining F upsilon(-/-) mice progress normally to term, but die from
massive haemorrhage within 2 hours or birth. Considered together with
the milder phenotypes generally associated with deficiencies of other
clotting factors(6,7), our findings demonstrate the primary role of t
he common coagulation pathway and the absolute requirement for functio
nal factor V for prothrombinase activity. They also provide direct evi
dence for the existence of other critical haemostatic functions for th
rombin in addition to fibrin clot formation, and identify a previously
unrecognized role for the coagulation system in early mammalian devel
opment.